E-LIB Suche - Ergebnisse für: Robbrecht, Debbie G. J

1

Quantification and clinical validation of the selective MET..:

Sikkema, Barend J. ; Mathijssen, Ron H.J. ; Robbrecht, Debbie G.J....
Journal of Pharmaceutical and Biomedical Analysis. 240 (2024) - p. 115962 , 2024

Link: https://doi.org/10.1016/..

2

Treatment Patterns and Use of Immune Checkpoint Inhibitors ..:

Richters, Anke ; Robbrecht, Debbie G.J. ; Meijer, Richard P....
European Urology Open Science. 59 (2024) - p. 50-54 , 2024

Link: https://doi.org/10.1016/..

3

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) sco..:

Rijnders, Maud ; Nakauma-González, J. Alberto ; Robbrecht, Debbie G. J....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

"If only I had", patients' experiences during early oncolog..:

van Sasse van IJsselt, Maaike E. A. ; van der Biessen, Diane A. J. ; van Puffelen, Andrea J...
Supportive Care in Cancer. 31 (2023) 5 - p. , 2023

Link: https://doi.org/10.1007/..

5

Genome‐wide aneuploidy detected by mFast‐SeqS in circulatin..:

Mendelaar, Pauline A. J. ; Robbrecht, Debbie G. J. ; Rijnders, Maud...
Molecular Oncology. 16 (2022) 10 - p. 2086-2097 , 2022

Link: https://doi.org/10.1002/..

6

A blood-based immune marker for resistance to pembrolizumab..:

Rijnders, Maud ; Robbrecht, Debbie G. J. ; Oostvogels, Astrid A. M....
Cancer Immunology, Immunotherapy. 72 (2022) 3 - p. 759-767 , 2022

Link: https://doi.org/10.1007/..

7

ModraDoc006, an oral docetaxel formulation in combination w..:

Vermunt, Marit A. C. ; Robbrecht, Debbie G. J. ; Devriese, Lot A....
Cancer Reports. 4 (2021) 4 - p. , 2021

Link: https://doi.org/10.1002/..

8

Impact of progression at baseline and on-treatment progress..:

Robbrecht, Debbie G. ; Delanoy, Nicolas ; Tannock, Ian F....
European Journal of Cancer. 125 (2020) - p. 142-152 , 2020

Link: https://doi.org/10.1016/..

9

A first-in-human phase 1 and pharmacological study of TAS-1..:

Robbrecht, Debbie G. J. ; Lopez, Juanita ; Calvo, Emiliano...
British Journal of Cancer. 124 (2020) 2 - p. 391-398 , 2020

Link: https://doi.org/10.1038/..

10

Treatment Patterns and Use of Immune Checkpoint Inhibitors ..:

Richters, Anke ; Robbrecht, Debbie G J ; Meijer, Richard P...
https://boris.unibe.ch/191598/. , 2024

Link: https://boris.unibe.ch/1..

11

Treatment Patterns and Use of Immune Checkpoint Inhibitors ..:

Richters, Anke ; Robbrecht, Debbie G.J ; Meijer, Richard P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776918/. , 2023

Link: http://www.ncbi.nlm.nih...

12

"If only I had", patients' experiences during early oncolog..:

van Sasse van IJsselt, Maaike E. A ; van der Biessen, Diane A. J ; van Puffelen, Andrea J..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121491/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Anti–PD-1 Efficacy in Patients with Metastatic Urothelial C..:

Rijnders, Maud ; Balcioglu, Hayri E ; Robbrecht, Debbie G.J...
Rijnders , M , Balcioglu , H E , Robbrecht , D G J , Oostvogels , A A M , Wijers , R , Aarts , M J B , Hamberg , P , van Leenders , G J L H , Nakauma-González , J A , Voortman , J , Westgeest , H M , Boormans , J L , de Wit , R , Lolkema , M P , van der Veldt , A A M & Debets , R 2022 , ' Anti–PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8 þ T cells ' , Clinical Cancer Research , vol. 28 , no. 1 , pp. 215-226 . https://doi.org/10.1158/1078-0432.CCR-20-3319. , 2022

Link: https://pure.eur.nl/en/p..

14

A blood-based immune marker for resistance to pembrolizumab..:

Rijnders, Maud ; Robbrecht, Debbie G. J ; Oostvogels, Astrid A. M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947015/. , 2022

Link: http://www.ncbi.nlm.nih...

15

ModraDoc006, an oral docetaxel formulation in combination w..:

Vermunt, Marit A. C ; Robbrecht, Debbie G. J ; Devriese, Lot A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388171/. , 2021

Link: http://www.ncbi.nlm.nih...